Literature DB >> 15156427

The feasibility of a community-based directly administered antiretroviral therapy program.

Amy Rock Wohl1, Wendy H Garland, Kathleen Squires, Mallory Witt, Robert Larsen, Andrea Kovacs, Shannon Hader, Paul J Weidle.   

Abstract

Improved treatment-adherence support programs are needed to help human immunodeficiency virus (HIV)-infected persons comply with complex highly active antiretroviral treatment (HAART) regimens. In an experimental directly administered antiretroviral therapy (DAART) program, treatment-naive and treatment-experienced persons who experienced failure of no more than 1 prior regimen were recruited from 3 public HIV/AIDS clinics in Los Angeles County. For 6 months, trained community workers observed ingestion of 1 of 2 daily HAART doses, 5 days per week, and questioned the patient about the second dose, which enabled intense adherence monitoring and real-time intervention. From November 2001 through November 2003, there were 67 DAART patients enrolled (69% Latino, 21% African American, and 9% white; 63% with annual income of <10,000 dollars). Preliminary findings show that a DAART program based in 3 public HIV/AIDS clinics was feasible in a low-income urban population. Effective communication between the DAART staff, the medical providers, and the pharmacy is essential for the successful implementation of this program.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15156427     DOI: 10.1086/421401

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

Review 2.  Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Authors:  S Rueda; L Y Park-Wyllie; A M Bayoumi; A M Tynan; T A Antoniou; S B Rourke; R H Glazier
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 3.  Implementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence.

Authors:  Jennifer Leeman; Yun Kyung Chang; Eun Jeong Lee; Corrine I Voils; Jamie Crandell; Margarete Sandelowski
Journal:  J Adv Nurs       Date:  2010-09       Impact factor: 3.187

4.  How does directly observed therapy work? The mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru.

Authors:  Sonya Shin; Maribel Muñoz; Jhon Zeladita; Sam Slavin; Adolfo Caldas; Eduardo Sanchez; Miriam Callacna; Christian Rojas; Jorge Arevalo; Jose Luis Sebastian; Jaime Bayona
Journal:  Health Soc Care Community       Date:  2010-12-08

5.  Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.

Authors:  Cynthia R Pearson; Mark Micek; Jane M Simoni; Eduardo Matediana; Diane P Martin; Stephen Gloyd
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

6.  Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.

Authors:  Chinazo O Cunningham; Nancy L Sohler; Nina A Cooperman; Karina M Berg; Alain H Litwin; Julia H Arnsten
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

7.  Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996.

Authors:  Robert S Levine; Nathaniel C Briggs; Barbara S Kilbourne; William D King; Yvonne Fry-Johnson; Peter T Baltrus; Baqar A Husaini; George S Rust
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

8.  A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.

Authors:  Andrea Bradley-Ewing; Domonique Thomson; Megan Pinkston; Kathy J Goggin
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

9.  Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability.

Authors:  Patricia A Garvie; Joanne Lawford; Patricia M Flynn; Aditya H Gaur; Marvin Belzer; George D McSherry; Chengcheng Hu
Journal:  J Adolesc Health       Date:  2008-10-18       Impact factor: 5.012

10.  Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia.

Authors:  Kwasi E Torpey; Mushota E Kabaso; Liya N Mutale; Mpuma K Kamanga; Albert J Mwango; James Simpungwe; Chiho Suzuki; Ya Diul Mukadi
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.